How NVIDIA’s GPU‑Powered AI is Revolutionizing Drug Discovery and Genomics

1. NVIDIA SDK Platform: CLARA

CLARA is NVIDIA’s medical SDK platform that provides capabilities across medical devices, pharmaceuticals, imaging, genomics, and smart hospitals, delivering tailored acceleration for each use case.

CLARA Discovery, a key solution for drug‑discovery, leverages NVIDIA AI and HPC to accelerate the entire workflow.

2. Using AI/HPC to Accelerate Drug‑Discovery Workflows

The early stages of pharmaceutical R&D involve target discovery, chemical molecule generation, protein structure prediction, docking scoring, and free‑energy calculations. AI methods, especially Transformer‑based models, offer significant speed advantages over traditional HPC.

Transformer models such as MegaMolBART and ProtTrans have demonstrated effective acceleration of molecular generation and protein structure prediction.

3. BioNeMo – AI‑Native Service Framework

Based on experience with large language models, NVIDIA introduced BioNeMo, a cloud‑ready service framework for drug‑discovery researchers that supports large‑scale language models and is optimized for NVIDIA GPUs.

BioNeMo offers multiple pre‑trained Transformer models for chemical molecule generation, protein sequence prediction, and DNA embedding, and can be deployed as a visualized cloud service.

4. GPU‑Accelerated Genomics Pipelines

At the 2022 NVIDIA GTC, a Stanford team demonstrated that GPU acceleration reduced whole‑human genome sequencing to 7 hours 18 minutes, covering wet‑lab and computational analysis.

Three stages of sequencing—primary analysis, secondary alignment and variant calling, and tertiary large‑scale data processing—can all be accelerated using GPU‑optimized tools such as TensorFlow, PyTorch, TensorRT, CLARA Parabricks, RAPIDS, and MONAI.

5. CLARA Parabricks – High‑Throughput DNA/RNA Sequencing

CLARA Parabricks is a GPU‑accelerated toolkit for high‑throughput, high‑precision DNA and RNA sequencing, supporting over 60 modules for alignment, quality control, and variant identification.

6. RAPIDS – GPU‑Accelerated Data Science for Tier‑3 Genomics

RAPIDS provides an end‑to‑end GPU‑accelerated data‑science SDK, including cuDF for data processing, cuML for traditional machine learning, and cuGraph for graph analytics, enabling faster single‑cell RNA‑seq clustering, regression, and visualization.

7. Benchmark Highlights

GPU versions of Gromacs and VASP achieve up to 80× speedup over CPU on NVIDIA A100 and V100 GPUs. In a BioBank case study, processing 500 k exomes dropped from 1 hour on CPU to 5 minutes on GPU, reducing cost by 60%.

Overall, NVIDIA’s GPU‑based solutions—CLARA, BioNeMo, CLARA Parabricks, and RAPIDS—provide comprehensive acceleration across all stages of drug discovery and genomics, delivering substantial performance gains and cost efficiencies.